Drugs / NRCT-101
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06673368 Comparator | Feb → Jul 2025 | attention deficit-hyperactivity disorder | Neurocentria, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NRCT-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06673368 ↗ |